Health
Study directly compares Zepbound and Wegovy for weight-loss results
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others?
The question was explored in a new study published this month in The New England Journal of Medicine.
Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a 72-week clinical trial.
WEIGHT-LOSS MEDICATIONS MAY ALSO BENEFIT COMMON MEDICAL PROBLEM, STUDY FINDS
The randomized, controlled trial — called SURMOUNT-5 — included 751 people throughout the U.S. and Puerto Rico who had obesity but not type 2 diabetes.
“Doctors, insurance companies and patients are always asking, ‘Which drug is more effective?’” said Dr. Louis Aronne, director of the Comprehensive Weight Control Center and the Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medicine, in the release. “This study allowed us to do a direct comparison.”
Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a 72-week clinical trial. (iStock)
“The results are consistent with — in fact, almost identical to — what we’ve seen in trials in which these drugs were evaluated independently,” added Aronne, who was a principal investigator in the trial.
The study found that tirzepatide achieved greater weight loss, with participants shedding about 50 pounds (20.2% of their body weight).
“Doctors, insurance companies and patients are always asking, ‘Which drug is more effective?’”
The group taking semaglutide lost an average of 33 pounds or 13.7% of their baseline weight, according to a press release summarizing the study outcome.
Overall, 32% of the people taking tirzepatide lost at least 25% of their body weight; semaglutide users lost around 16%.
WEIGHT LOSS, DIABETES DRUGS CAN CAUSE MOOD CHANGES: WHAT TO KNOW ABOUT BEHAVIORAL SIDE EFFECTS
Tirzepatide users also reported a “greater reduction in waist circumference” than those on semaglutide.
The likely reason for tirzepatide’s greater effectiveness is that it uses a “dual mechanism of action,” according to Aronne.
The randomized, controlled trial — called SURMOUNT-5 — included 751 people in the U.S. and Puerto Rico who had obesity but not type 2 diabetes. (Steve Christo – Corbis/Corbis via Getty Images)
“Whereas semaglutide works by activating receptors for a hormone called glucagon-like peptide 1, or GLP-1, tirzepatide mimics not only GLP-1, but also an additional hormone, glucose-dependent insulinotropic peptide (GIP),” the release stated.
“Together, these actions reduce hunger, lower blood-glucose levels and affect fat cell metabolism.”
WEIGHT-LOSS DRUGS’ IMPACT ON CANCER RISK REVEALED IN NEW STUDY
Additional trials are actively exploring whether tirzepatide also reduces the risk of heart attack and stroke, a benefit that has been linked to semaglutide.
The study was led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian. It was also conducted with the University of Texas McGovern Medical School, the David Geffen School of Medicine at the University of California, Los Angeles, the University College Dublin and Eli Lilly (maker of Zepbound).
The study found that tirzepatide achieved greater weight loss, with participants shedding about 50 pounds (20.2% of their body weight). (iStock)
The participants all received guidance regarding nutrition and exercise.
The reported side effects were very similar for the two drugs, with 44% of people experiencing nausea and 25% having abdominal pain.
WEIGHT-LOSS DRUGS TO GET SURPRISING ENDORSEMENT FROM GLOBAL HEALTH GIANT
Dr. Ada Londono, M.D., a board-certified obesity and internal medicine primary care physician with PlushCare — a virtual health platform offering primary care, therapy and weight management services — said she was not surprised by the study’s findings.
“The results are consistent with prior trials, confirming tirzepatide’s advantage over semaglutide’s single GLP-1 action,” Londono, who is based in New York City, told Fox News Digital.
Beyond weight loss, semaglutide has also shown potential benefits for cardiovascular health, sleep apnea and kidney disease. (iStock)
Beyond weight loss, semaglutide has also shown potential benefits for cardiovascular health, sleep apnea and kidney disease, she noted.
“These findings highlight the need for continued research to understand tirzepatide’s broader health impacts,” she said. “It’s encouraging to see ongoing studies exploring the full potential of GLP-1 medications beyond weight management.”
Londono said these treatments can come with side effects.
SEMAGLUTIDE FOUND TO HAVE SHOCKING BENEFIT FOR LIVER DISEASE PATIENTS IN NEW STUDY
“Most people on these medications only report mild symptoms, but some have experienced more serious reactions, such as pancreatitis,” she told Fox News Digital.
“This underscores the importance of reviewing your medical history and discussing any concerns with your healthcare provider.”
Potential limitations
The study did have some limitations — chiefly that it was not a blinded analysis and participants knew which medication they were receiving. This could introduce some level of bias, the researchers acknowledged.
Londono pointed out that while the study’s findings are “promising,” it was funded by Eli Lilly, the manufacturer of Zepbound.
“This may raise questions about potential conflicts of interest,” she said. “Additionally, the open-label design and 72-week duration may limit objectivity and long-term insight.”
An expert emphasized that people should work with a physician to choose a weight-loss medication that matches personal goals and health status. (iStock)
While the study primarily looked at the impact of the medications, experts agreed there are other factors that play a role in successful weight management.
“Weight loss is biological, but it’s also emotional, and whole-person support can make the difference between short-term results and sustainable health,” Dr. Rekha Kumar, chief medical officer at the weight care program Found and a practicing endocrinologist in New York City, told Fox News Digital.
Kumar emphasized the importance of working with a physician to choose a weight-loss medication that matches the patient’s personal goals and health status.
“Both Wegovy and Zepbound have demonstrated clinically significant weight reduction.”
“For example, if a patient has fatty liver, we will choose the GLP-1 that is proven to work best for liver disease,” she said.
Looking ahead, the researchers plan to investigate new versions of weight-loss drugs, including retatrutide, which mimics the hormones GLP-1, GIP and glucagon, according to the release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Even though drugs like tirzepatide and semaglutide work really well, better than anything we have ever seen, we still have people who don’t respond to them,” said Aronne.
“So, moving forward, we want to keep trying to do better.”
“Across the respective clinical trial programs and in SURMOUNT-5, both Wegovy and Zepbound have demonstrated clinically significant weight reduction,” Novo Nordisk, maker of Wegovy, said in a statement. (iStock)
A spokesperson from Novo Nordisk, the company that makes Wegovy (semaglutide), sent a statement to Fox News Digital.
“Across the respective clinical trial programs and in SURMOUNT-5, both Wegovy and Zepbound have demonstrated clinically significant weight reduction,” the company said. “It is important to recognize that the comprehensive management of obesity goes beyond weight reduction alone.”
For more Health articles, visit www.foxnews.com/health
The spokesperson also pointed out that in a previous trial, adults who were obese or overweight and who took Wegovy along with diet and exercise lost an average of 15.2% of their weight (~35 pounds) at the two-year mark, compared with 2.6% (~6 pounds) for patients taking a placebo.
NEWYou can now listen to Fox News articles!
Colorectal cancer, once considered a disease of older age, is becoming a crisis for younger adults. New research shows one group getting hit the hardest – those without a college degree.
A recent study from the American Cancer Society analyzed data from over 101,000 adults aged 25 to 49 who died from colorectal cancer between 1994 and 2023.
While death rates remained stable for college graduates, they climbed significantly for those without a bachelor’s degree, the findings showed.
WIDESPREAD HABIT MAY RAISE COLORECTAL CANCER RISK MORE THAN YOU THINK
For young adults with a high school education or less, the mortality rate rose from 4.0 to 5.2 per 100,000 people, while the rate for those with at least a bachelor’s degree stayed flat, at approximately 2.7 per 100,000.
This does not mean that a degree offers some kind of biological protection, researchers cautioned.
Colorectal cancer, once considered a disease of older age, is becoming a crisis for younger adults. (iStock)
The difference is likely driven by the conditions in which people live and work, which often correlate with education levels, the researchers noted.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study suggests that the higher death rates are likely driven by differences in the prevalence of risk factors, including obesity, physical inactivity, smoking and diet, which are “known to be elevated among children and young adults with lower [socioeconomic status].”
Because the study relied on death certificates, researchers couldn’t say exactly why college graduates had better outcomes.
Because the researchers didn’t have the patients’ actual medical records, they couldn’t see things like frequency of screenings or treatment options, which would impact survival outcomes. (iStock)
Certificates typically list the cause of death, age, race and education level, but they do not include a person’s full medical history.
RED FLAGS FOR COLORECTAL CANCER THAT WARRANT SCREENINGS BEFORE 45 YEARS OF AGE
Because the researchers didn’t have the patients’ actual medical records, they couldn’t see things like frequency of screenings or treatment options, which would impact survival outcomes.
CLICK HERE FOR MORE HEALTH STORIES
Colorectal cancer is now the leading cause of cancer death for men under 50 and the second leading cause for women in the same age group, according to recent statistics.
While colorectal cancer death rates remained stable for college graduates, they climbed significantly for those without a bachelor’s degree, the findings showed. (iStock)
Because the disease is highly treatable when caught early, the U.S. Preventive Services Task Force (USPSTF) lowered the recommended screening age from 50 to 45 in 2021.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Common signs and symptoms of colorectal cancer can include a change in bowel habits, such as diarrhea, constipation or narrowing of the stool, that lasts for more than a few days, according to the American Cancer Society.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Other signs that warrant seeing a doctor include blood in the stool or a persistent feeling of needing to go to the bathroom but being unable to go.
The research was published in JAMA Oncology.
NEWYou can now listen to Fox News articles!
A young woman who started vaping at the age of 15 has been given just 18 months to live — after being diagnosed with lung cancer in her early 20s.
Kayley Boda, 22, of Manchester, in the United Kingdom, was engaging in heavy vaping on a regular basis when she started coughing up a brown substance with “grainy bits” in it in January 2025, news agency SWNS reported.
The retail assistant said doctors turned her away eight times, telling her she had a chest infection — until she began coughing up blood.
SMOKING AND VAPING MAY BE BANNED AT ONE STATE’S MOST POPULAR BEACHES AND PARKS: HERE’S WHY
After seven biopsies, Boda was diagnosed with lung cancer. She underwent surgery to remove the lower lobe of her right lung, as well as chemotherapy — and in February 2026, got the all-clear, the same source reported.
Two months later, though, doctors said the cancer had come back in the pleural lining. Now she’s been given 18 months to live.
Kayley Boda, 22, is shown in the hospital. She started coughing up a brown substance with “grainy bits” in January 2025, she said. She had been vaping since the age of 15. (SWNS)
The young woman has now issued a warning to others to be aware of the dangers of vaping.
Boda said she smoked a bit as a young teenager. She took up vaping after that.
Then, “a few months after I switched from reusable vapes to disposable ones, I started coughing up brown, grainy mucus,” as SWNS reported.
TOURISTS MAY FACE STEEP FINES AND JAIL TIME FOR VAPES AT THIS VACATION HOT SPOT
“Doctors turned me away eight times with a chest infection. … Then I started coughing up blood, so they did an X-ray and found a shadow on my lung,” she added.
“They told me they were 99% sure, [since I was] so young, that it wasn’t cancer, so not to worry about it. When I got the results back, and they told me it was lung cancer, it felt so surreal.”
Boda said she was “very naive” before her diagnosis and thought that “something like this would never happen to me.”
She said that she had surgery to remove half of her right lung.
“After the surgery, I started chemo and I had a terrible reaction to it. I couldn’t lift my head up. I was throwing up blood. I was urinating blood. I couldn’t eat. I couldn’t sleep.”
VACATION HOT SPOT CRACKS DOWN ON VAPING WITH JAIL THREATS AND HEFTY FINES
She said that when she got the “all clear [in Feb. 2026], it felt amazing, but just two months later I was told the cancer had come back, and I have 18 months to live.”
She added, “I’m 22. This isn’t meant to happen to somebody my age.”
“Stay off the vapes because they will catch up with you.”
She blames her cancer on vaping, she said.
“My symptoms started a few months after I started disposable vapes, and there’s no lung cancer in my family,” she said. “I haven’t vaped for three months, I’ve made my partner stop, I’ve made my mom stop, I’m urging all my friends to stop. Stay off the vapes,” she continued, “because they will catch up with you.”
When doctors did an X-ray, they found a shadow on Boda’s right lung. She was later diagnosed with lung cancer and has undergone surgery to remove the lower lobe of her right lung, as well as chemotherapy. (SWNS)
She said she’d been using reusable vapes since the age of 15 and began using disposable vapes a few months before her cancer symptoms started.
DISPOSABLE VAPES MORE TOXIC AND CARCINOGENIC THAN CIGARETTES, STUDY SHOWS
In November 2024, when she developed a rash all over her body, doctors said it could have been due to shingles, chicken pox or scabies, she told SWNS.
‘Nothing worked’
“I got treated for all three, and nothing worked,” Boda said. “It got to the point where I was cutting myself from scratching so hard.”
A few months after that, she began coughing up a dark brown mucus, with “grainy bits, the consistency of sugar, in it,” she said. When the coughing continued, she visited the doctor’s office, but was told it could be scarring from pneumonia or a chest infection, she also said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
It wasn’t until March 2025 that she began coughing up bright red blood. At that point, doctors gave her a chest X-ray and told her they’d found a shadow on her lower right lung.
Over the next four months, she had seven biopsies as doctors took samples from the “shadow.” In August, when she went to get the results, she was told she had stage one lung cancer.
Boda is shown in the hospital. She was diagnosed with lung cancer and had surgery to remove the lower lobe of her right lung, as well as chemotherapy. (SWNS)
In September 2025, she had surgery to remove the lower lobe of her right lung, and the surrounding lymph nodes. During the surgery, doctors upstaged her cancer from stage one to stage three after finding cancer in six surrounding lymph nodes, she said.
Following the surgery, Boda was unable to breathe properly and had to learn to walk all over again.
“The oncologist said this is so rare.”
After finishing chemotherapy in February 2026, Kayley was given the all clear, leaving her feeling elated.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
However, just a month after that, she began experiencing extreme chest pains and was told by doctors she had a pleural effusion — a build-up of fluid in the lungs. She had the fluid removed, but when doctors tested it, they discovered her cancer had returned to the pleural lining of her lungs, giving her 18 months to live.
“The oncologist said this is so rare, and usually something they see in patients that are 80 years old,” she said, as SWNS reported.
Increasingly, vacation hot spots are enforcing strict bans on the use of e-cigarettes in public venues. (iStock)
Boda claimed that doctors were unable to pin her cancer to a specific cause — but told her that smoking and vaping definitely didn’t help.
Since her diagnosis, she has stopped and is urging others to stop, too.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
She’s hoping to raise the thousands of dollars needed for treatment to try to prolong her life, she said.
Last year, Fox News Digital reported on the case of a Pennsylvania woman, 26, who said she vaped for just one year before her lungs collapsed. She was 22 when she took up the habit, she said in an interview.
“Everybody warned me about it, but I didn’t listen — I wish that I did,” she said.
CLICK HERE FOR MORE HEALTH ARTICLES
Dr. David Campbell, clinical director and program director at Recover Together Bend in Oregon, told Fox News Digital at that time that signs of collapsed lungs include sharp chest or shoulder pain, shortness of breath and difficulty breathing.
Lung issues are just one of the many health issues linked to vaping, he warned. The habit can also increase the risk of heart disease and stroke, as well as exposure to harmful heavy metals.
Melissa Rudy of Fox News Digital contributed reporting.
NEWYou can now listen to Fox News articles!
The key to feeling better in a fast, overstimulated world might be surprisingly simple: Live a little more like your grandparents.
A growing social media trend, dubbed “nonnamaxxing,” draws inspiration from the slower, more intentional rhythms associated with an Italian grandmother.
The lifestyle is often linked to activities like preparing home-cooked meals, spending time outdoors and making meaningful connections.
MARTHA STEWART SHARES 7 TIPS FOR AGING WELL: ‘LOOK GOOD, FEEL GOOD, BE GOOD’
“Nonnamaxxing is a 2026 trend that embraces the slower, more intentional lifestyle of an Italian grandmother (a Nonna). Think cooking from scratch, long family meals, daily walks, gardening and less screen time,” Erin Palinski-Wade, a New Jersey-based registered dietitian, told Fox News Digital.
Nonnamaxxing, derived from the name for an Italian grandmother, is a trend that incorporates lifestyle habits hundreds of years in the making. (iStock)
Stepping away from screens and toward real-world interaction can have measurable benefits, according to California-based psychotherapist Laurie Singer.
“We know that interacting with others in person, rather than spending time on screens, significantly improves mental health,” she told Fox News Digital, adding that social media often fuels comparison and lowers self-esteem.
LONELINESS MAY BE SILENTLY ERODING YOUR MEMORY, NEW RESEARCH REVEALS
Living more like previous generations isn’t purely driven by nostalgia. Cooking meals from scratch, for example, has been linked to better nutrition and more mindful eating patterns.
Adopting traditional mealtime habits can improve diet quality and support both physical and mental health, especially when meals are shared regularly with others, Palinski-Wade noted.
One longevity expert stresses that staying healthy isn’t just about food — it’s also about joy and community. (iStock)
There’s also a psychological benefit to slowing down and focusing on one task at a time. Anxiety often stems from unfinished or avoided tasks, Singer noted, and engaging in hands-on activities can counteract that.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Nonnamaxxing encourages us to be present around a task, like gardening, baking or knitting, or just taking a mindful walk, that delivers something ‘real,’” she said.
CLICK HERE FOR MORE HEALTH STORIES
Palinski-Wade cautions against turning the trend into another source of pressure, noting that a traditional “nonna” lifestyle often assumes a different pace of life.
The key, she said, is adapting the mindset, not replicating it perfectly.
Nonnamaxxing, derived from the name for an Italian grandmother, is a trend that incorporates lifestyle habits hundreds of years in the making. (iStock)
The goal is to reintroduce small, intentional moments that make you feel better.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
That might mean prioritizing a few shared meals each week, taking a walk without your phone or setting aside time for a simple hobby, the expert recommended.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Singer added, “Having a positive place to escape to, through whatever activities speak to us and make us happy, isn’t generational – it’s human.”
-
New Jersey30 seconds agoDan Levy’s new Netflix comedy ‘Big Mistakes’ was filmed at these New Jersey locations
-
New Mexico6 minutes agoWarm start to the week across New Mexico
-
North Carolina13 minutes agoNorth Carolina High School Football Program Promotes From Within
-
North Dakota18 minutes agoRetired Game & Fish Director facing new charge of molesting a child – KVRR Local News
-
Ohio25 minutes agoOhio Secretary of State Democratic primary pits outsider vs. insider – Signal Ohio
-
Oklahoma31 minutes agoPutnam City West moves to virtual learning after student incident
-
Oregon37 minutes agoOregon Ducks Safety Target Elijah Butler Nearing Crucial Point in Recruitment
-
Pennsylvania43 minutes agoOfficials react to Pennsylvania abortion ruling, Medicaid ban struck down